Related Articles
Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
Treatment of cancer cachexia in mice by combination of dsRNA-dependent protein kinase inhibitor and medroxyprogesterone acetate
Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice
The AP-1/NF-κB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia
Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: An in vitro and in vivo study